|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Development of methods of male contraception: impact of the World Health Organization Task Force显示文摘Objective:To give an historical record of the research of the World Health Organization (WHO) Task Force to develop methods of male contraception; to examine the social, political, medical, pharmaceutical, funding, and other factors that influenced progress; and to suggest reasons why such methods are only now becoming available. Design:Review of basic and clinical research over 30 years. Setting: Task force of a multinational Objective:To give an historical agency and collaborating agencies. Conclusion(s): Through the involvement of many international scientists, the WHO Task Force has uniquely contributed to the exploratory phases of the research in male contraception and by its multicenter contraceptive efficacy studies has accelerated progress towards the ideal hormonal method. Despite an adverse climate involving social and political attitudes, funding constraints, and pharmaceutical industry hesitations, WHO formed coalitions with governments and international agencies to sustain research with results that apply to men in culturally diverse populations and thereby to influence activities across the whole range of global reproductive health and family planning. | Geoffrey M.H.Waites Sc.D. | 2003 | Asian Journal of Andrology2003，5，3： | 6 |
| 2 | 营养支持在危重病人中的作用显示文摘综述了疾病与损伤、营养不良及免疫反应之间的关系,某些特殊营养物,如氨基酸(精氨酸和谷氨酰胺),膳食核苷酸和脂肪酸的免疫调节与代谢作用,营养支持与危重疾病之间的关系,以及用肠内营养制剂IMPACF进行的动物实验研究和临床研究。结果提示,精氨酸、谷氨酰氨、RNA和鱼油中的W-3脂肪酸可增强免疫功能,对患有免疫抑制的病人(如大手术、输血、脓毒症、大创伤及接受治疗的恶性肿瘤病人等)有重要的价值。 | J.Wesley Alexander M.D. Sc.D. John M.Daly M.D. 邓高月 | 1996 | 中华临床营养杂志1996，14，4： | 4 |
| 3 | The development and potential applications of a Pb-Al Alloy显示文摘 | Jerome F. Cole Sc.D. Frank E. Goodwin Sc.D | 1990 | JOM1990，，6： | 1 |
| 4 | Surgical unit time utilization review: Resource utilization and management implications显示文摘 | Toby Gordon Sc.D. Sharon Paul Alan Lyles Sc.D. Joan Fountain | 1988 | Journal of Medical Systems1988，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员